Vaxcyte, Inc.

NASDAQ:PCVX

96.63 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -402.266-223.485-100.077-89.217-50.274-29.485-0.017
Depreciation & Amortization 10.1719.1963.4571.4051.2321.0370.001
Deferred Income Tax -11.225000.3010.0010.0510
Stock Based Compensation 48.7623.6510.7295.4341.1850.7490
Change In Working Capital 81.3212.737-37.00535.273.9081.8950.001
Accounts Receivables 00000.8681.2660
Inventory 00002.87-1.1870
Accounts Payables 11.2252.896-12.4726.1020.8681.2660
Other Working Capital 70.0959.841-24.5359.168-0.6980.550.001
Other Non Cash Items -23.557.3051.5030.179-3.197-4.7130
Operating Cash Flow -296.79-170.597-121.393-46.628-47.145-30.466-0.015
Investing Activities:
Investments In Property Plant And Equipment -67.877-5.848-6.555-1.155-1.195-1.774-0.001
Acquisitions Net 51.8150.0070.0260.0500.0010
Purchases Of Investments -1,329.896-102.745-336.3410000
Sales Maturities Of Investments 624.462183.171130.5620000
Other Investing Activites -51.8150.08-0.206000.0010
Investing Cash Flow -773.31174.585-212.308-1.105-1.195-1.773-0.001
Financing Activities:
Debt Repayment 000-0.061-0.278-0.283-0.188
Common Stock Issued 636.043856.4813.896264.00742.94262.4730
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 3.775.0673.9110.92441.84562.4730.232
Financing Cash Flow 639.813861.54717.796374.8741.56762.190.044
Other Information:
Effect Of Forex Changes On Cash -6.6860.137-0.4390.087-0.34100
Net Change In Cash -437.206765.672-316.344327.224-7.11429.9510.028
Cash At End Of Period 397.451835.52869.856386.258.97666.090.036